Vistusertib T1961
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity.
CAS nr:
1009298-59-2
Purity:
98%
Molecular Weight:
462,54
SMILES:
C(=O)(c1cc(ccc1)c1ccc2c(nc(nc2n1)N1[C@H](COCC1)C)N1[C@H](COCC1)C)NC
Formula:
C25H30N6O3
Pathway:
PI3K/Akt/mTOR signaling,PI3K/Akt/mTOR signaling,Apoptosis,Autophagy,Cytoskeletal Signaling,PI3K/Akt/mTOR signaling,MAPK,PI3K/Akt/mTOR signaling
Target:
mTOR,PI3K,Apoptosis,Autophagy,Akt,Akt,S6 Kinase,S6 Kinase
